These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 30402845

  • 1. MicroRNA-556-3p promotes the progression of esophageal cancer via targeting DAB2IP.
    Lu HB.
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6816-6823. PubMed ID: 30402845
    [Abstract] [Full Text] [Related]

  • 2. miRNA-556-3p promotes human bladder cancer proliferation, migration and invasion by negatively regulating DAB2IP expression.
    Feng C, Sun P, Hu J, Feng H, Li M, Liu G, Pan Y, Feng Y, Xu Y, Feng K, Feng Y.
    Int J Oncol; 2017 Jun; 50(6):2101-2112. PubMed ID: 28440444
    [Abstract] [Full Text] [Related]

  • 3. miR-1307-3p promotes tumor growth and metastasis of hepatocellular carcinoma by repressing DAB2 interacting protein.
    Chen S, Wang L, Yao B, Liu Q, Guo C.
    Biomed Pharmacother; 2019 Sep; 117():109055. PubMed ID: 31176165
    [Abstract] [Full Text] [Related]

  • 4. MiR-490-3p inhibited the proliferation and metastasis of esophageal squamous cell carcinoma by targeting HMGA2.
    Kang NN, Ge SL, Zhang RQ, Huang YL, Liu SD, Wu KM.
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8298-8305. PubMed ID: 30556870
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-487a promotes proliferation of esophageal cancer cells by inhibiting p62 expression.
    Ma JB, Hu SL, Zang RK, Su Y, Liang YC, Wang Y.
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1502-1512. PubMed ID: 30840272
    [Abstract] [Full Text] [Related]

  • 6. MicroRNA-373-3p inhibits prostate cancer progression by targeting AKT1.
    Qu HW, Jin Y, Cui ZL, Jin XB.
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6252-6259. PubMed ID: 30338790
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-889 promotes cell proliferation in colorectal cancer by targeting DAB2IP.
    Xiao Y, Li ZH, Bi YH.
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3326-3334. PubMed ID: 31081086
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma.
    Han Q, Zhang HY, Zhong BL, Wang XJ, Zhang B, Chen H.
    Med Sci Monit; 2016 Oct 23; 22():3925-3934. PubMed ID: 27771733
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-1290 promotes esophageal squamous cell carcinoma cell proliferation and metastasis.
    Li M, He XY, Zhang ZM, Li S, Ren LH, Cao RS, Feng YD, Ji YL, Zhao Y, Shi RH.
    World J Gastroenterol; 2015 Mar 21; 21(11):3245-55. PubMed ID: 25805931
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-1236-3p inhibits proliferation and invasion of breast cancer cells by targeting ZEB1.
    Liang TC, Fu WG, Zhong YS.
    Eur Rev Med Pharmacol Sci; 2019 Nov 21; 23(22):9988-9995. PubMed ID: 31799668
    [Abstract] [Full Text] [Related]

  • 14. MiR-1-3p suppresses cell proliferation and invasion and targets STC2 in gastric cancer.
    Ke J, Zhang BH, Li YY, Zhong M, Ma W, Xue H, Wen YD, Cai YD.
    Eur Rev Med Pharmacol Sci; 2019 Oct 21; 23(20):8870-8877. PubMed ID: 31696489
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.